Table 2 CRP levels
Before cCRT | Before Durvalumab | 3-month follow-up | 6-month follow-up | 9-month follow-up | 12-month follow-up | |
|---|---|---|---|---|---|---|
Patient values | 22 | 22 | 22 | 19 | 19 | 18 |
CRP ≤5 | 20 (91%) | 21 (95%) | 19 (86%) | 17 (89%) | 18 (95%) | 18 (100%) |
CRP > 5 | 2 (9%) | 1 (5%) | 3 (14%) | 2 (11%) | 1 (5%) | 0 |